Newmark Group Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Newmark Group Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||
consolidated net income | 29,511,000 | -15,949,000 | 64,051,000 | 24,340,000 | 23,416,000 | -26,316,000 | 53,341,000 | 14,154,000 | 11,229,000 | -16,349,000 | 12,125,000 | 37,912,000 | 61,794,000 | 714,000 | 185,109,000 | 163,256,000 | 585,191,000 | 44,578,000 | -5,127,000 | 99,524,000 | 642,000 | 14,238,000 | -16,327,000 | 122,569,000 | 32,064,000 | 23,406,000 | 39,559,000 | 115,558,000 | 4,294,000 | 32,487,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||
gains on originated mortgage servicing rights | -20,296,000 | -18,711,000 | -40,182,000 | -23,948,000 | -20,298,000 | -19,552,000 | -20,915,000 | -23,170,000 | -22,654,000 | -8,965,000 | -33,901,000 | |||||||||||||||||||
depreciation and amortization | 42,611,000 | 46,358,000 | 44,869,000 | 44,576,000 | 40,879,000 | 43,975,000 | 43,894,000 | 41,463,000 | 42,034,000 | 38,830,000 | 47,058,000 | 44,358,000 | 38,925,000 | 35,475,000 | 40,925,000 | 28,883,000 | 30,868,000 | 21,053,000 | 36,580,000 | 29,627,000 | 28,947,000 | 46,039,000 | 32,634,000 | 36,781,000 | 33,425,000 | 28,304,000 | 29,146,000 | 25,873,000 | 20,201,000 | 22,513,000 |
benefit for credit losses on the financial guarantee liability | 1,972,000 | 1,503,000 | -574,000 | |||||||||||||||||||||||||||
provision (reversal) for doubtful accounts | 4,080,000 | 1,559,000 | 601,000 | 265,000 | ||||||||||||||||||||||||||
equity-based compensation and allocation of net income to limited partnership units and fpus | 60,140,000 | 74,346,000 | 59,720,000 | 48,749,000 | 25,486,000 | 51,443,000 | 54,942,000 | 29,547,000 | 19,610,000 | 35,648,000 | 35,338,000 | 44,088,000 | 41,987,000 | 16,899,000 | 40,603,000 | 19,669,000 | 281,777,000 | 14,296,000 | 56,215,000 | 50,770,000 | 10,860,000 | 12,914,000 | 13,871,000 | |||||||
employee loan amortization and other non-cash compensation expense | 38,877,000 | 32,359,000 | 32,084,000 | 29,700,000 | ||||||||||||||||||||||||||
deferred tax provision | 0 | 12,028,000 | -36,000 | |||||||||||||||||||||||||||
non-cash changes in acquisition related earn-outs | 200,000 | 188,000 | 188,000 | -3,312,000 | -1,104,000 | 383,000 | 4,789,000 | 187,000 | 3,000 | 191,000 | -2,498,000 | |||||||||||||||||||
unrealized (gains) on loans held for sale | -19,072,000 | -20,121,000 | -6,188,000 | -36,983,000 | 48,098,000 | -10,862,000 | -965,000 | -5,449,000 | -9,989,000 | -1,786,000 | -4,035,000 | 2,841,000 | ||||||||||||||||||
loan originations—loans held for sale | -2,158,500,000 | -1,737,433,000 | -3,334,363,000 | -2,092,971,000 | -1,631,220,000 | -1,567,047,000 | -1,659,385,000 | -1,474,616,000 | -2,976,883,000 | -802,191,000 | -2,019,703,000 | -1,992,241,000 | -2,140,238,000 | -1,671,022,000 | -3,145,062,000 | -2,713,552,000 | -1,118,939,000 | -2,164,595,000 | -4,088,340,000 | -3,226,603,000 | -2,513,573,000 | -2,545,715,000 | -1,271,991,000 | -4,012,751,000 | -1,944,040,000 | -1,554,443,000 | -2,674,707,000 | -3,278,137,000 | -1,249,137,000 | -1,410,690,000 |
loan sales—loans held for sale | 1,676,375,000 | 1,684,416,000 | 3,567,540,000 | 1,898,064,000 | 1,324,748,000 | 1,599,527,000 | 1,774,073,000 | 1,799,103,000 | 2,464,090,000 | 511,872,000 | 2,899,199,000 | 1,812,477,000 | 1,874,576,000 | 2,171,797,000 | 3,278,224,000 | 1,939,340,000 | 1,525,928,000 | 2,434,241,000 | 4,536,428,000 | 2,780,275,000 | 2,152,623,000 | 2,057,684,000 | 1,743,710,000 | 4,124,128,000 | 2,010,574,000 | 1,685,561,000 | 2,834,478,000 | 2,686,613,000 | 1,658,970,000 | 822,811,000 |
other | 511,000 | -42,000 | 7,910,000 | -10,722,000 | -4,539,000 | 6,273,000 | -9,501,000 | 6,544,000 | -1,151,000 | 5,843,000 | 522,000 | 353,000 | 686,000 | 611,000 | 940,000 | 895,000 | 890,000 | 885,000 | -494,000 | 877,000 | 51,000 | 2,971,000 | 1,026,000 | 1,189,000 | 878,000 | 1,167,000 | ||||
consolidated net income, adjusted for non-cash and non-operating items | -344,365,000 | 48,473,000 | 422,780,000 | -101,816,000 | -218,329,000 | 110,900,000 | 232,925,000 | 412,855,000 | -432,537,000 | -218,308,000 | 914,840,000 | -8,659,000 | -130,665,000 | 626,374,000 | 449,584,000 | -678,651,000 | 212,178,000 | 317,786,000 | 553,669,000 | -410,638,000 | -288,565,000 | -470,140,000 | 619,528,000 | 199,648,000 | 155,297,000 | 185,342,000 | 274,703,000 | -521,443,000 | 487,692,000 | -527,419,000 |
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||
receivables | -10,172,000 | 42,320,000 | -62,314,000 | 9,506,000 | -28,521,000 | 99,005,000 | -92,753,000 | 3,765,000 | -5,350,000 | 25,029,000 | -17,074,000 | 9,462,000 | 13,393,000 | 36,663,000 | -55,971,000 | -104,070,000 | -16,076,000 | -15,154,000 | 3,014,000 | 22,541,000 | 36,188,000 | 62,000,000 | -27,728,000 | -9,416,000 | -19,586,000 | 4,709,000 | -62,237,000 | -22,766,000 | -25,113,000 | -19,374,000 |
loans, forgivable loans and other receivables from employees and partners | -35,596,000 | -122,330,000 | -2,083,000 | -24,026,000 | -24,671,000 | -161,074,000 | -33,667,000 | -31,754,000 | -47,384,000 | -130,453,000 | -31,013,000 | -36,005,000 | -35,463,000 | -29,123,000 | -29,024,000 | -15,772,000 | -25,971,000 | -7,726,000 | 2,120,000 | -14,254,000 | -10,509,000 | -105,274,000 | -59,152,000 | -48,936,000 | -13,814,000 | -39,995,000 | -24,442,000 | -35,217,000 | -25,327,000 | -24,583,000 |
right-of-use assets | 18,401,000 | -12,919,000 | 39,608,000 | -8,630,000 | 36,676,000 | 28,244,000 | ||||||||||||||||||||||||
receivable from related parties | 0 | 326,000 | 0 | 0 | 0 | 8,262,000 | ||||||||||||||||||||||||
other assets | 23,829,000 | -62,464,000 | 48,397,000 | -31,822,000 | -9,149,000 | -4,271,000 | 4,404,000 | 7,364,000 | -11,407,000 | -9,397,000 | 61,952,000 | -65,949,000 | 47,496,000 | -34,785,000 | -53,954,000 | -20,123,000 | 74,147,000 | 8,788,000 | 21,570,000 | -20,828,000 | 49,275,000 | -28,253,000 | -50,358,000 | -19,392,000 | -24,889,000 | -18,602,000 | 17,168,000 | -2,418,000 | -10,611,000 | -14,063,000 |
accrued compensation | -27,267,000 | -115,978,000 | 82,948,000 | 13,482,000 | -15,070,000 | -96,503,000 | 68,656,000 | -1,317,000 | 511,000 | -90,112,000 | 43,000 | -5,234,000 | 11,428,000 | -108,570,000 | 36,067,000 | -238,240,000 | 143,166,000 | -24,230,000 | 22,822,000 | 1,616,000 | -10,065,000 | -89,742,000 | 26,633,000 | 54,949,000 | 20,428,000 | -62,051,000 | 15,280,000 | 36,968,000 | 33,019,000 | -35,069,000 |
right-of-use liability | -17,687,000 | 10,178,000 | -42,542,000 | 5,053,000 | -37,181,000 | -32,192,000 | -7,623,000 | -27,017,000 | -11,295,000 | 6,189,000 | ||||||||||||||||||||
accounts payable, accrued expenses and other liabilities | 7,500,000 | 26,778,000 | -77,846,000 | 53,697,000 | 40,598,000 | -15,820,000 | 42,834,000 | 21,261,000 | -19,818,000 | 27,398,000 | 5,460,000 | 24,501,000 | -51,304,000 | -13,990,000 | -68,881,000 | -58,943,000 | 116,586,000 | 6,839,000 | -42,384,000 | 33,348,000 | -66,649,000 | -6,730,000 | 66,598,000 | -7,657,000 | 61,741,000 | -29,970,000 | 83,521,000 | 29,505,000 | 9,745,000 | 30,114,000 |
payables to related parties | 5,615,000 | 6,212,000 | -6,045,000 | -688,000 | -2,839,000 | 2,928,000 | 3,895,000 | -6,511,000 | 7,961,000 | -8,446,000 | -2,227,000 | 585,000 | -17,136,000 | 13,484,000 | 3,415,000 | 1,620,000 | -9,348,000 | 4,679,000 | -1,618,000 | 2,260,000 | -12,369,000 | -14,262,000 | 17,824,000 | |||||||
net cash from operating activities | -379,742,000 | -179,404,000 | 402,577,000 | -85,244,000 | -258,486,000 | -68,783,000 | 219,977,000 | 413,540,000 | -500,638,000 | -398,840,000 | 931,608,000 | -74,299,000 | -163,121,000 | 502,155,000 | 277,848,000 | -1,111,699,000 | 494,182,000 | 290,960,000 | 563,356,000 | -385,955,000 | 593,345,000 | 174,805,000 | 179,177,000 | 39,433,000 | 303,993,000 | -515,371,000 | 469,405,000 | -590,394,000 | ||
cash flows from investing activities: | ||||||||||||||||||||||||||||||
purchase of non-marketable investments | 0 | 0 | 0 | -312,000 | 0 | 0 | -368,000 | -2,355,000 | -7,000,000 | |||||||||||||||||||||
purchases of fixed assets | -6,502,000 | -5,444,000 | -6,019,000 | -9,182,000 | -9,266,000 | -7,042,000 | -11,540,000 | -10,187,000 | -15,460,000 | -18,174,000 | -22,174,000 | -22,486,000 | -8,860,000 | -8,669,000 | -8,439,000 | -5,179,000 | -3,660,000 | -2,443,000 | -3,444,000 | -4,205,000 | -2,128,000 | -9,849,000 | -11,079,000 | -12,707,000 | -4,804,000 | -5,936,000 | -10,230,000 | -1,658,000 | -7,414,000 | -1,714,000 |
net cash from investing activities | -6,502,000 | -5,444,000 | -6,129,000 | -10,682,000 | -9,266,000 | -7,354,000 | -11,540,000 | 95,314,000 | -15,460,000 | -118,059,000 | -22,174,000 | -22,518,000 | -73,475,000 | 426,796,000 | 29,100,000 | 438,208,000 | -4,437,000 | -9,783,000 | -16,108,000 | -4,058,000 | -2,236,000 | 18,800,000 | -26,183,000 | -5,044,000 | -28,433,000 | 2,872,000 | 24,252,000 | -29,452,000 | ||
cash flows from financing activities: | ||||||||||||||||||||||||||||||
proceeds from warehouse facilities | 2,158,500,000 | 1,737,433,000 | 3,334,363,000 | 2,092,971,000 | 1,631,220,000 | 1,567,047,000 | 1,659,385,000 | 1,474,616,000 | 2,976,883,000 | 802,191,000 | 2,019,703,000 | 1,992,241,000 | 2,140,238,000 | 1,671,022,000 | 3,145,062,000 | 2,713,552,000 | 1,118,939,000 | 2,164,595,000 | 4,088,340,000 | 3,226,603,000 | 2,513,573,000 | 2,545,715,000 | 1,271,991,000 | 4,012,751,000 | 1,944,040,000 | 1,554,443,000 | ||||
principal payments on warehouse facilities | -1,688,802,000 | -1,670,576,000 | -3,565,855,000 | -1,900,032,000 | -1,331,786,000 | -1,572,251,000 | -1,770,211,000 | -1,796,631,000 | -2,473,112,000 | -511,896,000 | -2,898,649,000 | -1,810,471,000 | -1,877,360,000 | -2,150,011,000 | -3,278,698,000 | -1,939,393,000 | -1,525,801,000 | -2,408,764,000 | -4,537,472,000 | -2,780,365,000 | -2,152,799,000 | -2,052,041,000 | -1,743,203,000 | -4,125,086,000 | -2,010,591,000 | -1,667,084,000 | ||||
borrowing of debt | 305,000,000 | 115,000,000 | 10,000,000 | 60,000,000 | 75,000,000 | 700,000,000 | 680,000,000 | 25,000,000 | 0 | 225,000,000 | 0 | 0 | 25,000,000 | 30,000,000 | 0 | 0 | 0 | 365,000,000 | ||||||||||||
repayment of debt | -205,000,000 | -15,000,000 | -110,000,000 | -35,000,000 | 0 | -575,000,000 | -735,000,000 | 0 | -140,000,000 | -25,000,000 | -30,000,000 | -200,000,000 | -10,000,000 | -30,000,000 | -15,000,000 | -50,000,000 | ||||||||||||||
treasury stock repurchases | -30,351,000 | -89,551,000 | -55,507,000 | -37,161,000 | -5,158,000 | -18,909,000 | -13,609,000 | -105,265,000 | -145,035,000 | -30,893,000 | -151,204,000 | -84,132,000 | -45,919,000 | -9,283,000 | -3,385,000 | -20,087,000 | ||||||||||||||
earnings and tax distributions to limited partnership interests and other noncontrolling interests | -9,983,000 | -12,869,000 | -6,332,000 | -9,907,000 | -6,193,000 | -16,225,000 | -3,720,000 | -9,123,000 | -11,103,000 | -11,429,000 | -6,271,000 | -16,001,000 | ||||||||||||||||||
dividends to stockholders | -5,546,000 | -5,420,000 | -5,098,000 | -5,104,000 | -5,190,000 | -5,232,000 | -5,219,000 | -5,245,000 | -5,226,000 | -5,215,000 | -5,180,000 | -5,358,000 | -5,502,000 | -1,893,000 | -1,935,000 | -2,003,000 | -1,852,000 | -1,841,000 | -1,809,000 | -1,799,000 | -1,790,000 | -17,773,000 | -17,586,000 | -17,698,000 | ||||||
payments on acquisition earn-outs | 0 | -943,000 | 0 | 0 | 0 | -4,322,000 | 0 | -2,131,000 | -1,513,000 | -2,979,000 | -984,000 | -37,366,000 | -812,000 | -2,222,000 | 0 | -1,759,000 | -1,430,000 | -490,000 | -976,000 | -245,000 | -2,497,000 | -758,000 | ||||||||
deferred financing costs | -1,625,000 | -28,000 | -302,000 | -5,038,000 | -3,083,000 | -14,000 | -1,631,000 | -648,000 | -2,761,000 | -29,000 | -1,000,000 | |||||||||||||||||||
net cash from financing activities | 428,196,000 | 147,625,000 | -375,921,000 | 102,065,000 | 307,242,000 | 56,140,000 | -183,006,000 | -527,283,000 | 473,098,000 | 498,651,000 | -904,020,000 | 49,193,000 | 73,799,000 | -677,492,000 | -285,653,000 | 681,049,000 | -463,247,000 | -328,427,000 | -625,511,000 | 359,537,000 | 320,479,000 | 763,318,000 | -519,606,000 | -160,777,000 | -123,245,000 | -91,878,000 | -529,897,000 | 556,616,000 | ||
net increase in cash and cash equivalents and restricted cash | 41,952,000 | -37,223,000 | 20,527,000 | 6,139,000 | 25,431,000 | -18,429,000 | -43,000,000 | -18,248,000 | 5,414,000 | -47,624,000 | -162,797,000 | 251,459,000 | 21,295,000 | 7,558,000 | 26,498,000 | -47,250,000 | -78,263,000 | -30,476,000 | 15,549,000 | 129,717,000 | 47,556,000 | 8,984,000 | 27,499,000 | -49,573,000 | ||||||
cash and cash equivalents and restricted cash at beginning of period | 0 | 304,865,000 | 0 | 0 | 0 | 258,706,000 | 0 | 0 | 312,952,000 | 0 | 0 | 0 | 266,500,000 | 0 | 0 | 0 | 258,399,000 | 0 | 0 | 0 | 221,872,000 | 0 | 0 | 0 | 187,406,000 | 0 | 0 | 0 | 173,374,000 | |
cash and cash equivalents and restricted cash at end of period | 41,952,000 | 267,642,000 | 20,527,000 | 6,139,000 | 39,490,000 | 238,709,000 | -18,429,000 | -43,000,000 | 294,704,000 | 5,414,000 | -47,624,000 | -162,797,000 | 517,959,000 | 21,295,000 | 7,558,000 | 26,498,000 | 211,149,000 | -78,263,000 | -30,476,000 | 15,549,000 | 351,589,000 | 47,556,000 | 8,984,000 | 27,499,000 | 137,833,000 | -201,652,000 | 11,793,000 | 83,252,000 | 292,013,000 | |
lease impairment | ||||||||||||||||||||||||||||||
income from an equity method investment | -1,030,000 | -1,250,000 | -1,250,000 | 2,250,000 | 19,000 | -1,843,000 | -3,176,000 | |||||||||||||||||||||||
realized losses on marketable securities | ||||||||||||||||||||||||||||||
unrealized losses on marketable securities | 14,000 | 141,000 | 70,000 | 132,000 | 346,000 | |||||||||||||||||||||||||
unrealized losses (gains) on non-marketable investments | 10,000 | 0 | ||||||||||||||||||||||||||||
payments for acquisitions, net of cash acquired and proceeds from divestitures | 0 | 0 | 0 | -99,885,000 | ||||||||||||||||||||||||||
proceeds from the sale of marketable securities | 0 | 0 | 0 | 437,820,000 | 55,361,000 | 460,291,000 | 3,781,000 | 31,631,000 | 0 | 147,000 | 0 | 34,591,000 | 0 | 10,402,000 | 13,098,000 | 9,106,000 | 44,445,000 | 0 | -763,000 | 52,196,000 | ||||||||||
proceeds from the exercise of redemption option | 0 | |||||||||||||||||||||||||||||
purchase of marketable securities | 0 | |||||||||||||||||||||||||||||
payments for intangible assets | 0 | |||||||||||||||||||||||||||||
purchase of mortgage servicing rights | 0 | 0 | -108,000 | -92,000 | -298,000 | -983,000 | -516,000 | -1,099,000 | -509,000 | |||||||||||||||||||||
repurchase agreements and securities loaned | 0 | 0 | 0 | -140,007,000 | ||||||||||||||||||||||||||
purchase of limited partnership interests | -1,023,000 | |||||||||||||||||||||||||||||
deferred tax benefit | 0 | 0 | -136,000 | -24,405,000 | 0 | 0 | -94,000 | 117,565,000 | 0 | 439,000 | ||||||||||||||||||||
unrealized (gains) losses on loans held for sale | -13,881,000 | |||||||||||||||||||||||||||||
unrealized (gains) losses on marketable securities | -2,000 | |||||||||||||||||||||||||||||
benefit from credit losses on the financial guarantee liability | 106,000 | 1,251,000 | -771,000 | 822,000 | -220,000 | 2,803,000 | -3,070,000 | 0 | 222,000 | 14,480,000 | ||||||||||||||||||||
benefit from doubtful accounts | -910,000 | -871,000 | 108,000 | 507,000 | -1,945,000 | 1,107,000 | 907,000 | 843,000 | 3,788,000 | 1,741,000 | 533,000 | 2,874,000 | 1,190,000 | 1,692,000 | 28,000 | 194,000 | 2,754,000 | |||||||||||||
employee loan amortization | 31,198,000 | 14,246,000 | 28,266,000 | 25,043,000 | 25,380,000 | 23,142,000 | 21,409,000 | 20,704,000 | 18,861,000 | 25,425,000 | 17,216,000 | 19,455,000 | 17,322,000 | 23,403,000 | 18,267,000 | 17,458,000 | 14,468,000 | 7,299,000 | 13,184,000 | 11,067,000 | 7,437,000 | 9,099,000 | ||||||||
unrealized gains on loans held for sale | -9,203,000 | 3,176,000 | -12,422,000 | -13,276,000 | 6,827,000 | 7,838,000 | -15,126,000 | |||||||||||||||||||||||
net decrease in cash and cash equivalents and restricted cash | -19,997,000 | |||||||||||||||||||||||||||||
nasdaq earn-out recognition | 0 | 0 | 0 | |||||||||||||||||||||||||||
unrealized (gains) on investments | -1,599,000 | |||||||||||||||||||||||||||||
change in valuation of derivative asset | 1,087,000 | 313,000 | 292,000 | -221,000 | 6,802,000 | 5,602,000 | 6,570,000 | 5,771,000 | 22,512,000 | -21,173,000 | ||||||||||||||||||||
right-of-use asset | 1,306,000 | 34,894,000 | 18,681,000 | -740,000 | ||||||||||||||||||||||||||
proceeds from the sale of limited partnership interests | 2,873,000 | 0 | 0 | 4,025,000 | ||||||||||||||||||||||||||
redemption and repurchase of limited partnership interests | 321,000 | 0 | ||||||||||||||||||||||||||||
unrealized (gains)/losses on loans held for sale | -3,937,000 | |||||||||||||||||||||||||||||
loss (income) from an equity method investment | -5,686,000 | -4,952,000 | -3,583,000 | 0 | ||||||||||||||||||||||||||
provision/(reversals) for/of credit losses on the financial guarantee liability | 1,152,000 | 677,000 | -284,000 | 195,000 | 1,634,000 | 1,123,000 | -4,701,000 | -1,648,000 | ||||||||||||||||||||||
(gains) losses from an equity method investment | ||||||||||||||||||||||||||||||
realized losses (gains) on marketable securities | ||||||||||||||||||||||||||||||
unrealized losses (gains) on marketable securities | ||||||||||||||||||||||||||||||
payments for acquisitions, net of cash acquired | 0 | 0 | -10,822,000 | -15,404,000 | -4,558,000 | -38,971,000 | 0 | 0 | 0 | -5,850,000 | -15,727,000 | -2,009,000 | ||||||||||||||||||
distributions from equity method investment | ||||||||||||||||||||||||||||||
purchase of debt securities | ||||||||||||||||||||||||||||||
gain on originated mortgage servicing rights | -26,752,000 | -35,427,000 | -36,199,000 | -67,342,000 | -53,006,000 | -34,598,000 | -38,967,000 | -29,287,000 | -35,186,000 | -21,433,000 | -17,254,000 | -6,389,000 | ||||||||||||||||||
realized gain on marketable securities | 0 | 0 | 7,470,000 | -2,400,000 | ||||||||||||||||||||||||||
unrealized gain on marketable securities | 283,000 | 0 | 80,130,000 | -35,781,000 | -796,000 | |||||||||||||||||||||||||
unrealized loss (gains) on non-marketable investments | -1,000 | |||||||||||||||||||||||||||||
right of use asset | 23,087,000 | -34,684,000 | 9,854,000 | 36,190,000 | -15,320,000 | 13,179,000 | 7,459,000 | |||||||||||||||||||||||
right of use liability | -16,087,000 | 33,814,000 | -6,014,000 | -31,316,000 | 17,800,000 | -13,679,000 | -7,481,000 | |||||||||||||||||||||||
gains from an equity method investment | ||||||||||||||||||||||||||||||
earnings distributions to limited partnership interests and other noncontrolling interests | -20,818,000 | -537,000 | -2,996,000 | -4,859,000 | -6,515,000 | |||||||||||||||||||||||||
unrealized gain on investment | 0 | |||||||||||||||||||||||||||||
(gains) income from an equity method investment | ||||||||||||||||||||||||||||||
realized (gain) loss on marketable securities | -7,996,000 | 51,000 | ||||||||||||||||||||||||||||
realized loss (gains) on non-marketable investments | 941,000 | 0 | ||||||||||||||||||||||||||||
purchase of msrs | ||||||||||||||||||||||||||||||
settlement of pre-spin-off related party receivables | 0 | 0 | 6,848,000 | 27,044,000 | ||||||||||||||||||||||||||
gain on originated msrs | -28,246,000 | -22,436,000 | -48,138,000 | |||||||||||||||||||||||||||
non-cash changes in acquisition related earnouts | 221,000 | 338,000 | 414,000 | 1,102,000 | -12,813,000 | |||||||||||||||||||||||||
securities loaned | 140,000,000 | 0 | -33,278,000 | 33,278,000 | 0 | 0 | -36,735,000 | 11,897,000 | -8,822,000 | -10,085,000 | 43,745,000 | -8,580,000 | -547,000 | |||||||||||||||||
realized loss (gains) on marketable securities | -2,693,000 | -1,950,000 | 0 | |||||||||||||||||||||||||||
unrealized loss on marketable securities | ||||||||||||||||||||||||||||||
unrealized gains on marketable securities | -399,000 | 665,000 | -1,150,000 | -3,960,000 | ||||||||||||||||||||||||||
unrealized loss (gains) on marketable securities | ||||||||||||||||||||||||||||||
proceeds from bgc's purchase of exchangeable limited partnership units in newmark holdings | 0 | |||||||||||||||||||||||||||||
proceeds from issuance of epus | ||||||||||||||||||||||||||||||
payments to related parties | -13,000,000 | |||||||||||||||||||||||||||||
borrowings from related parties | 177,016,000 | |||||||||||||||||||||||||||||
proceeds from the ipo, net of underwriting discounts | ||||||||||||||||||||||||||||||
capital contribution | ||||||||||||||||||||||||||||||
earnings distributions to limited partnership interests and noncontrolling interests | 0 | -7,164,000 | -37,966,000 | -36,749,000 | -27,885,000 | -18,823,000 | -59,917,000 | -33,951,000 | ||||||||||||||||||||||
prepayment penalty on debt | ||||||||||||||||||||||||||||||
payment of deferred financing costs | -672,000 | -516,000 | -539,000 | -2,340,000 | -32,000 | -156,000 | -1,096,000 | -40,000 | -16,000 | |||||||||||||||||||||
change in fair value of contingent consideration | 89,000 | 208,000 | 238,000 | 193,000 | 236,000 | -215,000 | 219,000 | 134,000 | ||||||||||||||||||||||
unrealized (gains) on marketable securities | ||||||||||||||||||||||||||||||
unrealized gain on non-marketable investments | ||||||||||||||||||||||||||||||
unrealized (gains) loss on loans held for sale | 10,903,000 | -36,061,000 | ||||||||||||||||||||||||||||
(income) income from an equity method investment | ||||||||||||||||||||||||||||||
realized (gains) loss on marketable securities | 0 | 2,204,000 | ||||||||||||||||||||||||||||
unrealized (gains) loss on marketable securities | ||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash (used in) provide by operating activities: | ||||||||||||||||||||||||||||||
loss on non-marketable investments | 16,837,000 | |||||||||||||||||||||||||||||
net cash (used in) provide by operating activities | -652,401,000 | |||||||||||||||||||||||||||||
nasdaq recognition | 0 | |||||||||||||||||||||||||||||
equity-based compensation and allocation of net income to limited partnership units and fpus and issuance of common stock | ||||||||||||||||||||||||||||||
deferred tax provision/ | ||||||||||||||||||||||||||||||
realized gains on non-marketable investments | ||||||||||||||||||||||||||||||
benefit from uncollectible accounts | 242,000 | -70,000 | 689,000 | 956,000 | 1,154,000 | 159,000 | 1,077,000 | 1,140,000 | ||||||||||||||||||||||
distributions of earnings to bgc | ||||||||||||||||||||||||||||||
pre-acquisition distributions relating to bpf acquisitions | ||||||||||||||||||||||||||||||
equity-based compensation and allocations of net income to limited partnership units and fpus | 56,648,000 | |||||||||||||||||||||||||||||
realized gain on non-marketable investments | ||||||||||||||||||||||||||||||
realized gains on marketable securities | -2,244,000 | 0 | ||||||||||||||||||||||||||||
changes in valuation of derivative asset | 8,214,000 | |||||||||||||||||||||||||||||
distributions from real estate lp | ||||||||||||||||||||||||||||||
purchases of non-marketable investments | -7,900,000 | |||||||||||||||||||||||||||||
purchases of mortgage servicing rights | -123,000 | |||||||||||||||||||||||||||||
proceeds from issuance of exchangeable preferred partnership units | -3,400,000 | 112,683,000 | ||||||||||||||||||||||||||||
fees relating to the ipo | ||||||||||||||||||||||||||||||
borrowings of debt | 45,000,000 | 60,000,000 | 50,000,000 | |||||||||||||||||||||||||||
payments of deferred financing costs | -1,282,000 | |||||||||||||||||||||||||||||
unrealized gain on measurement alternative investments | ||||||||||||||||||||||||||||||
valuation of derivative asset | 13,329,000 | -12,675,000 | -9,135,000 | |||||||||||||||||||||||||||
investment in cost method investments | -7,000,000 | 0 | -15,000,000 | -7,500,000 | ||||||||||||||||||||||||||
distributions to stockholders | -16,043,000 | |||||||||||||||||||||||||||||
nasdaq earn-out | ||||||||||||||||||||||||||||||
employee loan amortization and reserves | ||||||||||||||||||||||||||||||
payments for acquisitions, net of cash acquired and repurchase of noncontrolling interests | ||||||||||||||||||||||||||||||
borrowing of long-term debt | ||||||||||||||||||||||||||||||
repayment of long-term debt | -133,950,000 | -113,200,000 | -152,850,000 | -270,710,000 | ||||||||||||||||||||||||||
capital contribution from cantor | ||||||||||||||||||||||||||||||
distributions to noncontrolling interests | 0 | -100,000 | ||||||||||||||||||||||||||||
equity-based compensation and allocations of net income to limited partnership units | 40,263,000 | 58,104,000 | 25,809,000 | |||||||||||||||||||||||||||
amortization of deferred financing costs | 158,000 | 254,000 | 255,000 | |||||||||||||||||||||||||||
payments for acquisitions, net of cash acquired and repurchases of noncontrolling interests | -27,278,000 | |||||||||||||||||||||||||||||
proceeds from warehouse notes payable | 3,278,137,000 | 1,249,137,000 | 1,410,690,000 | |||||||||||||||||||||||||||
principal payments on warehouse notes payable | -2,686,916,000 | -1,659,045,000 | -820,651,000 | |||||||||||||||||||||||||||
pre-acquisition distributions relating to the bpf acquisition | ||||||||||||||||||||||||||||||
earnings distributions | ||||||||||||||||||||||||||||||
dividends to common stockholders | ||||||||||||||||||||||||||||||
payments for ipo offering costs | 0 | 0 | -8,870,000 | |||||||||||||||||||||||||||
net increase in cash and cash equivalents | 11,793,000 | 83,252,000 | 118,639,000 | |||||||||||||||||||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||||||||||||||||
cash paid during the period for: | ||||||||||||||||||||||||||||||
interest | 20,534,000 | 20,444,000 | 12,922,000 | |||||||||||||||||||||||||||
taxes | 869,000 | 15,000 | 19,000 | |||||||||||||||||||||||||||
proceeds from bgc's purchase of exchangeability limited partnership units in newmark holdings | 0 | 241,960,000 | ||||||||||||||||||||||||||||
employee loan amortization and impairment | 6,009,000 | |||||||||||||||||||||||||||||
cash acquired, net of purchases of noncontrolling interest | ||||||||||||||||||||||||||||||
net cash provided (used in) by investing activities | 42,473,000 | |||||||||||||||||||||||||||||
secured loans | -49,001,000 | |||||||||||||||||||||||||||||
net cash provided (used in) by financing activities | 666,560,000 | |||||||||||||||||||||||||||||
equity-based compensation | ||||||||||||||||||||||||||||||
unrealized losses (gains) on loans held for sale | ||||||||||||||||||||||||||||||
restricted cash | ||||||||||||||||||||||||||||||
net cash provided (used in) by operating activities | ||||||||||||||||||||||||||||||
distributions relating to bpf acquisitions | ||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | ||||||||||||||||||||||||||||||
cash and cash equivalents at end of period | ||||||||||||||||||||||||||||||
supplemental disclosure of noncash investing and financing activities: | ||||||||||||||||||||||||||||||
net assets contributed by bgc partners’ | ||||||||||||||||||||||||||||||
debt assumed from bgc | ||||||||||||||||||||||||||||||
accrued offering costs | ||||||||||||||||||||||||||||||
supplemental noncash activity for the purchase of noncontrolling interest: | ||||||||||||||||||||||||||||||
total stockholders’ equity | ||||||||||||||||||||||||||||||
noncontrolling interest |
We provide you with 20 years of cash flow statements for Newmark Group stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Newmark Group stock. Explore the full financial landscape of Newmark Group stock with our expertly curated income statements.
The information provided in this report about Newmark Group stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.